Updated Results on MURANO and ASCEND in CLL

(MedPage Today) -- At the American Society of Clinical Oncology virtual annual meeting, one abstract measured the impact of premature venetoclax discontinuation/interruption on outcomes in relapsed/refractory chronic lymphocytic leukemia (CLL)...